A citation-based method for searching scientific literature

Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
Times Cited: 100







List of co-cited articles
1094 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
Xuemei Huang, Alvaro Alonso, Xuguang Guo, David M Umbach, Maya L Lichtenstein, Christie M Ballantyne, Richard B Mailman, Thomas H Mosley, Honglei Chen. Mov Disord 2015
86
5

Insulin resistance and exendin-4 treatment for multiple system atrophy.
Fares Bassil, Marie-Hélène Canron, Anne Vital, Erwan Bezard, Yazhou Li, Nigel H Greig, Seema Gulyani, Dimitrios Kapogiannis, Pierre-Olivier Fernagut, Wassilios G Meissner. Brain 2017
56
8

Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Marissa Ong, Heidi Foo, Russell Jude Chander, Ming-Ching Wen, Wing Lok Au, Yih Yian Sitoh, Louis Tan, Nagaendran Kandiah. J Neurol Sci 2017
18
27


Body mass index, sitting time, and risk of Parkinson disease.
Elin Roos, Alessandra Grotta, Fei Yang, Rino Bellocco, Weimin Ye, Hans-Olov Adami, Karin Wirdefeldt, Ylva Trolle Lagerros. Neurology 2018
16
31

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.
Peng Feng, Xiangjian Zhang, Dongfang Li, Chenhui Ji, Ziyue Yuan, Ruifang Wang, Guofang Xue, Guanglai Li, Christian Hölscher. Neuropharmacology 2018
54
9

Epidemiology of Parkinson's disease.
Ole-Bjørn Tysnes, Anette Storstein. J Neural Transm (Vienna) 2017
793
5

Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway.
Justine Renaud, Valentina Bassareo, Jimmy Beaulieu, Annalisa Pinna, Michele Schlich, Carole Lavoie, Daniela Murtas, Nicola Simola, Maria-Grazia Martinoli. Neurobiol Aging 2018
19
26

Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.
Milena Pinto, Nadee Nissanka, Susana Peralta, Roberta Brambilla, Francisca Diaz, Carlos T Moraes. Mol Neurodegener 2016
41
12

Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.
Alice Biosa, Tiago F Outeiro, Luigi Bubacco, Marco Bisaglia. Mol Neurobiol 2018
39
12

Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
Chien-Tai Hong, Kai-Yun Chen, Weu Wang, Jing-Yuan Chiu, Dean Wu, Tsu-Yi Chao, Chaur-Jong Hu, Kai-Yin David Chau, Oluwaseun Adebayo Bamodu. Cells 2020
31
16

Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study.
Sang Youl Rhee, Kyung-Do Han, Hyemi Kwon, Se-Eun Park, Yong-Gyu Park, Yang-Hyun Kim, Soon-Jip Yoo, Eun-Jung Rhee, Won-Young Lee. Diabetes Care 2020
23
21

Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?
Malú G Tansey, Tamy C Frank-Cannon, Melissa K McCoy, Jae Kyung Lee, Terina N Martinez, Fiona E McAlpine, Kelly A Ruhn, Thi A Tran. Front Biosci 2008
84
4

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.
Mary Elizabeth Patti, Atul J Butte, Sarah Crunkhorn, Kenneth Cusi, Rachele Berria, Sangeeta Kashyap, Yoshinori Miyazaki, Isaac Kohane, Maura Costello, Robert Saccone,[...]. Proc Natl Acad Sci U S A 2003
4

The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells.
Sangeeta Ghosh, Nishant Patel, Douglas Rahn, Jenna McAllister, Sina Sadeghi, Geoffrey Horwitz, Diana Berry, Kai Xuan Wang, Russell H Swerdlow. Mol Pharmacol 2007
83
4





Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
Randy L Hunter, Natasa Dragicevic, Kristen Seifert, Dong Young Choi, Mei Liu, Hyoung-Chun Kim, Wayne A Cass, Patrick G Sullivan, Guoying Bing. J Neurochem 2007
250
4

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.
Marjolijn Bornebroek, Lonneke M L de Lau, Mendel D M Haag, Peter J Koudstaal, Albert Hofman, Bruno H C Stricker, Monique M B Breteler. Neuroepidemiology 2007
53
7

Glia: initiators and progressors of pathology in Parkinson's disease.
Glenda M Halliday, Claire H Stevens. Mov Disord 2011
284
4

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.
Honglei Chen, Eric Jacobs, Michael A Schwarzschild, Marjorie L McCullough, Eugenia E Calle, Michael J Thun, Alberto Ascherio. Ann Neurol 2005
344
4

Parkinson's disease.
Andrew J Lees, John Hardy, Tamas Revesz. Lancet 2009
4

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.
Taye H Hamza, Cyrus P Zabetian, Albert Tenesa, Alain Laederach, Jennifer Montimurro, Dora Yearout, Denise M Kay, Kimberly F Doheny, Justin Paschall, Elizabeth Pugh,[...]. Nat Genet 2010
535
4

Microglial activation and chronic neurodegeneration.
Melinda E Lull, Michelle L Block. Neurotherapeutics 2010
582
4

Overweight is more prevalent in patients with Parkinson's disease.
Hugo Morales-Briceño, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Juan Calleja-Castillo, Teresa Corona. Arq Neuropsiquiatr 2012
23
17

Is underweightness still a major problem in Parkinson's disease patients?
M Barichella, A Marczewska, A Vairo, M Canesi, G Pezzoli. Eur J Clin Nutr 2003
35
11




PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
Nicoletta Schintu, Lucia Frau, Marcello Ibba, Pierluigi Caboni, Arianna Garau, Ezio Carboni, Anna R Carta. Eur J Neurosci 2009
167
4


Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk.
S M Zhang, M A Hernán, H Chen, D Spiegelman, W C Willett, A Ascherio. Neurology 2002
149
4

Alcohol consumption and the incidence of Parkinson's disease.
Miguel A Hernán, Honglei Chen, Michael A Schwarzschild, Alberto Ascherio. Ann Neurol 2003
61
6

Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?
Camilla Scheele, Anders Rinnov Nielsen, Tomas B Walden, Dean A Sewell, Christian P Fischer, Robert J Brogan, Natasa Petrovic, Ola Larsson, Per A Tesch, Kristian Wennmalm,[...]. FASEB J 2007
71
5


Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.
TracyAnn Perry, Norman J Haughey, Mark P Mattson, Josephine M Egan, Nigel H Greig. J Pharmacol Exp Ther 2002
264
4

Use of antihypertensives and the risk of Parkinson disease.
Claudia Becker, Susan S Jick, Christoph R Meier. Neurology 2008
162
4

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
4

Insulin in central nervous system: more than just a peripheral hormone.
Ana I Duarte, Paula I Moreira, Catarina R Oliveira. J Aging Res 2012
181
4

High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.
Carl Julien, Cyntia Tremblay, Alix Phivilay, Line Berthiaume, Vincent Emond, Pierre Julien, Frédéric Calon. Neurobiol Aging 2010
197
4


Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Suzanne Craft, Laura D Baker, Thomas J Montine, Satoshi Minoshima, G Stennis Watson, Amy Claxton, Matthew Arbuckle, Maureen Callaghan, Elaine Tsai, Stephen R Plymate,[...]. Arch Neurol 2012
827
4

Incretin-based therapies for type 2 diabetes mellitus.
Julie A Lovshin, Daniel J Drucker. Nat Rev Endocrinol 2009
494
4

Weight loss in Parkinson's disease.
Honglei Chen, Shumin M Zhang, Miguel A Hernán, Walter C Willett, Alberto Ascherio. Ann Neurol 2003
191
4

Persistent organochlorine pesticides in serum and risk of Parkinson disease.
M G Weisskopf, P Knekt, E J O'Reilly, J Lyytinen, A Reunanen, F Laden, L Altshul, A Ascherio. Neurology 2010
99
4

Prospective study of coffee consumption and risk of Parkinson's disease.
K Sääksjärvi, P Knekt, H Rissanen, M A Laaksonen, A Reunanen, S Männistö. Eur J Clin Nutr 2008
98
4

Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease.
A Grandinetti, D M Morens, D Reed, D MacEachern. Am J Epidemiol 1994
173
4

Risk and protective factors for Parkinson's disease: a study in Swedish twins.
Karin Wirdefeldt, Margaret Gatz, Yudi Pawitan, Nancy L Pedersen. Ann Neurol 2005
91
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.